Alliqua, Inc. (HPLF) - Product Pipeline Analysis

GlobalData, March 2011, Pages: 21

Alliqua, Inc. (HPLF) - Product Pipeline Analysis

Summary

This report is a source for data, analysis and actionable intelligence on the Alliqua, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

2
List of Tables 3
List of Figures 3
Alliqua, Inc. - Business Description 4
Key Facts 5
Alliqua, Inc. - Major Products and Services 6
Alliqua, Inc. Pipeline Products by Equipment Type 7
Alliqua, Inc. Pipeline Products by Development Stage 8
Alliqua, Inc. Pipeline Products by Therapy Area 9
Alliqua, Inc. Pipeline Products by Milestone Summary 11
HepaMate 12
Product Status 12
Product Description 12
Product Milestone 12
HepaMate Clinical Trial 13
Hydress +Plus 13
Product Status 13
Product Description 13
Product Milestone 13
Transdermal Pain Patch 14
Product Status 14
Product Description 14
Product Milestone 14
Transdermal Pain Patch Clinical Trial 15
Alliqua, Inc. - Key Competitors 16
Alliqua, Inc. - Key Employees 17
Alliqua, Inc. - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Jan 06, 2011: Alliqua Appoints Five New Directors To Board 19
Jan 05, 2011: Alliqua Announces Ticker Symbol Change 19
Dec 22, 2010: HepaLife Announces Name Change To Alliqua 19
Nov 01, 2010: HepaLife Launches Alliqua To Focus On Development, Manufacturing And Marketing Of Proprietary Transdermal Drug Delivery Products 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

Fresenius SE
Vital Therapies, Inc.
Gambro AB

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Charter Schools - Global Outlook
• Sports and Fitness Nutrition - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Aerospace and Defense Industry - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Worldwide Industry & Market Opportunities and forecasts to 2014 for Microwaves Global Military & Space-Related Systems
• Defense Robotics - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020